The use of vaginal estriol and its effects on sexual intercourse and serum estriol levels in postmenopausal women.

IF 3 3区 医学 Q1 OBSTETRICS & GYNECOLOGY
Stany Rodrigues Campos de Paula, Maria Celia Mendes, Sergio Henrique Pires Okano, Rui Alberto Ferriani, Rosana Maria Reis, Lucia Alves da Silva Lara
{"title":"The use of vaginal estriol and its effects on sexual intercourse and serum estriol levels in postmenopausal women.","authors":"Stany Rodrigues Campos de Paula, Maria Celia Mendes, Sergio Henrique Pires Okano, Rui Alberto Ferriani, Rosana Maria Reis, Lucia Alves da Silva Lara","doi":"10.1097/GME.0000000000002589","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Vaginal estrogenization plays a crucial role in alleviating pain during sexual activity while low-dose vaginal estrogen therapy provides benefit often with no increase in systemic estrogen levels after use. This study aimed to compare the effects of estriol applied to the distal or proximal thirds of the vagina on dyspareunia in postmenopausal women, evaluate serum estriol levels, and assess sexual function.</p><p><strong>Methods: </strong>This prospective, randomized clinical trial included a total of 116 sexually active postmenopausal women with dyspareunia who were randomized to receive vaginal estriol (1.0 mg/application, every other day) for 12 weeks in the proximal estriol group (PEG) or distal estriol group (DEG), or a vaginal lubricant gel (VLG) before intercourse. Plasma estriol levels, coital pain (McGill Pain Questionnaire), sexual function (FSFI), and emotional status (HADS) were assessed at baseline and after 12 weeks. Statistical analyses included the Shapiro-Wilk test for normality, one-way ANOVA with Tukey's post-hoc test, χ2 test, and Pearson correlation as appropriate.</p><p><strong>Results: </strong>No significant changes in serum estriol levels were observed in any group after the intervention. PEG and DEG showed significant increases in FSFI total scores and all domains. The VLG group showed improvements in FSFI total scores and the domains of desire, arousal, lubrication, satisfaction, and pain. Intergroup analysis revealed that the PEG group showed significantly greater improvement in the lubrication domain compared with DEG (mean difference=0.70; 95% CI: 0.05-1.37; P=0.04) and VLG (mean difference=1.22; 95% CI: 0.58-1.86; P<0.01). All other domains showed no statistically significant differences between groups.</p><p><strong>Conclusions: </strong>Vaginal estriol, applied distally or proximally, improved dyspareunia and sexual function without increasing systemic estriol levels. Lubricant use also enhanced sexual function (except orgasm) and reduced pain comparably to estriol.</p>","PeriodicalId":18435,"journal":{"name":"Menopause: The Journal of The North American Menopause Society","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Menopause: The Journal of The North American Menopause Society","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/GME.0000000000002589","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Vaginal estrogenization plays a crucial role in alleviating pain during sexual activity while low-dose vaginal estrogen therapy provides benefit often with no increase in systemic estrogen levels after use. This study aimed to compare the effects of estriol applied to the distal or proximal thirds of the vagina on dyspareunia in postmenopausal women, evaluate serum estriol levels, and assess sexual function.

Methods: This prospective, randomized clinical trial included a total of 116 sexually active postmenopausal women with dyspareunia who were randomized to receive vaginal estriol (1.0 mg/application, every other day) for 12 weeks in the proximal estriol group (PEG) or distal estriol group (DEG), or a vaginal lubricant gel (VLG) before intercourse. Plasma estriol levels, coital pain (McGill Pain Questionnaire), sexual function (FSFI), and emotional status (HADS) were assessed at baseline and after 12 weeks. Statistical analyses included the Shapiro-Wilk test for normality, one-way ANOVA with Tukey's post-hoc test, χ2 test, and Pearson correlation as appropriate.

Results: No significant changes in serum estriol levels were observed in any group after the intervention. PEG and DEG showed significant increases in FSFI total scores and all domains. The VLG group showed improvements in FSFI total scores and the domains of desire, arousal, lubrication, satisfaction, and pain. Intergroup analysis revealed that the PEG group showed significantly greater improvement in the lubrication domain compared with DEG (mean difference=0.70; 95% CI: 0.05-1.37; P=0.04) and VLG (mean difference=1.22; 95% CI: 0.58-1.86; P<0.01). All other domains showed no statistically significant differences between groups.

Conclusions: Vaginal estriol, applied distally or proximally, improved dyspareunia and sexual function without increasing systemic estriol levels. Lubricant use also enhanced sexual function (except orgasm) and reduced pain comparably to estriol.

绝经后妇女阴道使用雌三醇及其对性交和血清雌三醇水平的影响。
目的:阴道雌激素在缓解性活动中的疼痛方面起着至关重要的作用,而低剂量阴道雌激素治疗在使用后通常不会增加全身雌激素水平。本研究旨在比较雌三醇应用于阴道远端或近三分之一处对绝经后妇女性交困难的影响,评估血清雌三醇水平,并评估性功能。方法:这项前瞻性随机临床试验包括116名性活跃的绝经后性交困难妇女,她们被随机分为近端雌三醇组(PEG)或远端雌三醇组(DEG),连续12周接受阴道雌三醇(1.0 mg/次,每隔一天),或性交前阴道润滑凝胶(VLG)。在基线和12周后评估血浆雌三醇水平、性交疼痛(McGill疼痛问卷)、性功能(FSFI)和情绪状态(HADS)。统计分析包括夏皮罗-威尔克检验的正态性,单因素方差分析与Tukey事后检验,χ2检验,并酌情使用Pearson相关。结果:干预后各组血清雌三醇水平均无明显变化。PEG和DEG在FSFI总分和各域均显著升高。VLG组在FSFI总分和欲望、兴奋、润滑、满足和疼痛等领域均有改善。组间分析显示,与DEG相比,PEG组在润滑领域的改善明显更大(平均差异=0.70;95% ci: 0.05-1.37;P=0.04)和VLG(平均差异=1.22;95% ci: 0.58-1.86;结论:阴道雌三醇,远端或近端应用,改善性交困难和性功能,而不增加全身雌三醇水平。与雌三醇相比,使用润滑剂也能增强性功能(除了性高潮)并减轻疼痛。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.40
自引率
7.40%
发文量
330
审稿时长
3-8 weeks
期刊介绍: ​Menopause, published monthly, provides a forum for new research, applied basic science, and clinical guidelines on all aspects of menopause. The scope and usefulness of the journal extend beyond gynecology, encompassing many varied biomedical areas, including internal medicine, family practice, medical subspecialties such as cardiology and geriatrics, epidemiology, pathology, sociology, psychology, anthropology, and pharmacology. This forum is essential to help integrate these areas, highlight needs for future research, and enhance health care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信